Harnessing the Immune System to fight cancer

Takis main focus is the development of therapeutic cancer vaccines against tumor antigens which play a role in tumor development and maintenance.

Our team
is recognized

for the conception and implementation of a number of innovative technologies with the goal to improve in vivo gene transfer, regulation of gene expression and immunogenicity.


Our Company

Luigi Aurisicchio, PhD

Master in "Regulatory Affairs", Chief Executive and Scientific Officer

Giuseppe Roscilli, PhD

Director, Drug Evaluation and Monoclonal Antibodies.

Emanuele Marra

Director, Cancer Vaccines and Biomarkers.

Takis as a CRO provides a variety of research services

in the areas of Oncology, Immunology, Infectious Diseases and novel preclinical models.


Scientific Collaborations

Takis Biotech

Harnessing the Immune System to fight cancer.

Takis S.r.l.

Via Castel Romano, 100
00128 Rome - Italy
P. I.V.A. 10700711004

Follow us